Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with < em > EPOR < /em > primary familial polycythemia on the island of New Caledonia
Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2023.284658. Online ahead of print.ABSTRACTNot available.PMID:38546672 | DOI:10.3324/haematol.2023.284658 (Source: Haematologica)
Source: Haematologica - March 28, 2024 Category: Hematology Authors: L éa Boulnois Margot Robles Nada Maaziz Bernard Aral Martin Gauthier Francis Duchene Marie-Am élie Goujart Betty Gardie Fran çois Girodon Source Type: research

Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with < em > EPOR < /em > primary familial polycythemia on the island of New Caledonia
Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2023.284658. Online ahead of print.ABSTRACTNot available.PMID:38546672 | DOI:10.3324/haematol.2023.284658 (Source: Haematologica)
Source: Haematologica - March 28, 2024 Category: Hematology Authors: L éa Boulnois Margot Robles Nada Maaziz Bernard Aral Martin Gauthier Francis Duchene Marie-Am élie Goujart Betty Gardie Fran çois Girodon Source Type: research

Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with < em > EPOR < /em > primary familial polycythemia on the island of New Caledonia
Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2023.284658. Online ahead of print.ABSTRACTNot available.PMID:38546672 | DOI:10.3324/haematol.2023.284658 (Source: Haematologica)
Source: Haematologica - March 28, 2024 Category: Hematology Authors: L éa Boulnois Margot Robles Nada Maaziz Bernard Aral Martin Gauthier Francis Duchene Marie-Am élie Goujart Betty Gardie Fran çois Girodon Source Type: research

Benefit of phlebotomy and low-dose aspirin in the prevention of vascular events in patients with < em > EPOR < /em > primary familial polycythemia on the island of New Caledonia
Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2023.284658. Online ahead of print.ABSTRACTNot available.PMID:38546672 | DOI:10.3324/haematol.2023.284658 (Source: Haematologica)
Source: Haematologica - March 28, 2024 Category: Hematology Authors: L éa Boulnois Margot Robles Nada Maaziz Bernard Aral Martin Gauthier Francis Duchene Marie-Am élie Goujart Betty Gardie Fran çois Girodon Source Type: research

Left Ventricular Global Longitudinal Strain to Assess Left Ventricular Systolic Dysfunction in Chronically Treated Cardiac Asymptomatic Hereditary Hemochromatosis With HFE C282Y Homozygosity
We have reported normal left ventricular (LV) systolic function (LVSF) at rest1 and during exercise2 with two-dimensional echocardiography (2DE) in our cohort of subjects with cardiac asymptomatic hereditary hemochromatosis (HH) with HFE C282Y homozygosity.1-4 Recently, subclinical LV systolic dysfunction (LVSDF) using LV global strain in newly diagnosed HH populations has been reported using both 2DE5 and cardiac magnetic resonance imaging.6 Cardiac asymptomatic HH subjects treated with chronic phlebotomy therapy are the most common type of encounters in practice; however, subclinical LVSDF in this group has previously no...
Source: Journal of the American Society of Echocardiography - March 26, 2024 Category: Cardiology Authors: Yukitaka Shizukuda, Stanislav Sidenko, My-Le Nguyen, Douglas R. Rosing Tags: Brief Research Communication Source Type: research

Iatrogenic blood loss from phlebotomy during adult extracorporeal membrane oxygenation: A retrospective cohort study
DISCUSSION: Phlebotomy for laboratory testing is a significant source of blood loss during ECMO in adults. Comprehensive patient blood management for adult ECMO patients should include strategies to reduce laboratory testing and/or phlebotomy volume during ECMO.PMID:38385665 | DOI:10.1111/trf.17729 (Source: Transfusion)
Source: Transfusion - February 22, 2024 Category: Hematology Authors: Michael Mazzeffi David Miller Angela Wang Venkat Kothandaraman Dustin Money Brian Clouse Akram M Zaaqoq Nicholas Teman Source Type: research

Iatrogenic blood loss from phlebotomy during adult extracorporeal membrane oxygenation: A retrospective cohort study
DISCUSSION: Phlebotomy for laboratory testing is a significant source of blood loss during ECMO in adults. Comprehensive patient blood management for adult ECMO patients should include strategies to reduce laboratory testing and/or phlebotomy volume during ECMO.PMID:38385665 | DOI:10.1111/trf.17729 (Source: Transfusion)
Source: Transfusion - February 22, 2024 Category: Hematology Authors: Michael Mazzeffi David Miller Angela Wang Venkat Kothandaraman Dustin Money Brian Clouse Akram M Zaaqoq Nicholas Teman Source Type: research

Traumatic subcutaneous emphysema following blood donation: A case report
DISCUSSION: Subcutaneous emphysema in blood donors is exceptionally rare but should be managed with clear communication. Donors should be reassured that the condition, although rare, is benign and self-resolving. Healthcare providers should be equipped to handle such rare complications, offering appropriate care and documenting incidents for future prevention.PMID:38380495 | DOI:10.1111/trf.17762 (Source: Transfusion)
Source: Transfusion - February 21, 2024 Category: Hematology Authors: Pallavi Singh Revathy Nair K Akshay Batra Satyendra Narayan Singh Source Type: research

Ischemic stroke as an initial performance of polycythemia vera in young adults: A case report and literature review
Medicine (Baltimore). 2024 Feb 16;103(7):e36953. doi: 10.1097/MD.0000000000036953.ABSTRACTINTRODUCTION: As the second leading cause of death and disability worldwide, stroke is mainly caused by atherosclerosis and cardiac embolism, particularly in older individuals. Nevertheless, in young and otherwise healthy individuals, the causes of stroke can be more diverse and may include conditions such as patent foramen ovale, vasculitis, coagulopathies, genetic factors, or other undetermined causes. Although these other causes of stroke account for a relatively small proportion compared to ischemic stroke, they are becoming incre...
Source: Atherosclerosis - February 16, 2024 Category: Cardiology Authors: Shuo Hui Jingru Zhao Tiantian Huo Lipeng Dong Yanzhao Xie Xinyao Wang Manli Zhang Source Type: research

Ischemic stroke as an initial performance of polycythemia vera in young adults: A case report and literature review
Medicine (Baltimore). 2024 Feb 16;103(7):e36953. doi: 10.1097/MD.0000000000036953.ABSTRACTINTRODUCTION: As the second leading cause of death and disability worldwide, stroke is mainly caused by atherosclerosis and cardiac embolism, particularly in older individuals. Nevertheless, in young and otherwise healthy individuals, the causes of stroke can be more diverse and may include conditions such as patent foramen ovale, vasculitis, coagulopathies, genetic factors, or other undetermined causes. Although these other causes of stroke account for a relatively small proportion compared to ischemic stroke, they are becoming incre...
Source: Atherosclerosis - February 16, 2024 Category: Cardiology Authors: Shuo Hui Jingru Zhao Tiantian Huo Lipeng Dong Yanzhao Xie Xinyao Wang Manli Zhang Source Type: research

Phlebotomy ‐free days in children hospitalized with common infections and their association with clinical outcomes
AbstractBackgroundPhlebotomy for hospitalized children has consequences (e.g., pain, iatrogenic anemia), and unnecessary testing is a modifiable source of waste in healthcare. Days without blood draws or phlebotomy-free days (PFDs) has the potential to serve as a hospital quality measure.ObjectiveTo describe: (1) the frequency of PFDs in children hospitalized with common infections and (2) the association of PFDs with clinical outcomes.Design, Settings and ParticipantsWe performed a cross-sectional study of children hospitalized 2018 –2019 with common infections at 38 hospitals using the Pediatric Health Information Syst...
Source: Journal of Hospital Medicine - February 13, 2024 Category: Hospital Management Authors: Megan E. Collins, Matt Hall, Samir S. Shah, Matthew J. Molloy, Paul L. Aronson, Jillian M. Cotter, Michael J. Steiner, Elisha McCoy, Michael J. Tchou, John R. Stephens, Jessica L. Markham Tags: ORIGINAL RESEARCH Source Type: research

Risk factors for disease progression and treatment goals in polycythemia vera
Clin Adv Hematol Oncol. 2024 Jan-Feb;22(1):31-42.ABSTRACTPolycythemia vera is a Philadelphia chromosome-negative myeloproliferative neoplasm characterized by the clonal proliferation of hematopoietic cells, leading to the overproduction of erythrocytes and the elaboration of inflammatory cytokines. Management is aimed at reducing the risk of thromboembolic events, alleviating the symptom burden, decreasing splenomegaly, and potentially mitigating the risk of disease progression. Existing treatment options include therapeutic phlebotomy and cytoreductive agents including hydroxyurea, pegylated recombinant interferon alpha 2...
Source: Clinical Advances in Hematology and Oncology - January 31, 2024 Category: Cancer & Oncology Authors: Julian A Waksal Nicole E Wagner John O Mascarenhas Source Type: research